DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/15617e/neuroblastoma_glob) has announced the addition of GlobalData's new report "Neuroblastoma Global Clinical Trials Review, Q1, 2011" to their offering.
GlobalData's clinical trial report, Neuroblastoma Global Clinical Trials Review, Q1, 2011 provides data on the Neuroblastoma clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Neuroblastoma.
It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope:
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status and trial success rate
- Review of key discontinued trials (suspended, withdrawn and terminated)
- Overview of the enrolment pattern by phase for the past decade
Reasons to Buy:
- Understand the dynamics of a particular indication as a whole
- Examine the performance of the trials in terms of their status, recruitment, success rates and others
- Obtain discontinued trial information for trials across the globe
- Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Key Topics Covered:
- Clinical Trials by Region
- Clinical Trials by Country
- Clinical Trials by Phase
- In Progress Trials by Phase
- Clinical Trials by Trial Status
- Unaccomplished Trials of Neuroblastoma
- Subjects Recruited Over a Period of Time
- Prominent Sponsors
- Top Companies Participating in Neuroblastoma Therapeutics Clinical Trials
- Prominent Drug Comparison
- Clinical Trial Profiles
- Clinical Trial Overview of Top Companies
- GE Healthcare
- Jennerex Biotherapeutics, Inc.
- Cell Medica Limited
- Novartis Pharmaceuticals Corporation
- The University of Texas M. D. Anderson Cancer Center
- Merck & Co., Inc.
- Genentech, Inc.
- Eli Lilly and Company
- United Therapeutics Corporation
For more information visit http://www.researchandmarkets.com/research/15617e/neuroblastoma_glob